Skip to main content
Livermore
Livermore
ZHEN

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

ASND holding history

Ascendis Pharma A/S in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ASND overviewAll 13F holders of ASNDFull Q2 2026 holdings

Shares (Q2 2026)
137,889
Value
$36.8M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of ASND by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026137,889$36.8M<0.1%+137,889NewHolders
Q1 20260$00.0%−519,516−100.0%Sold outHolders
Q4 2025519,516$110.8M0.1%+491,876+1,779.6%AddedHolders
Q3 202527,640$5.50M<0.1%−559,702−95.3%ReducedHolders
Q2 2025587,342$101.4M0.1%−537,841−47.8%ReducedHolders
Q1 20251,125,183$175.4M0.2%+229,199+25.6%AddedHolders
Q4 2024895,984$123.4M0.1%+232,060+35.0%AddedHolders
Q3 2024663,924$99.1M0.1%+126,162+23.5%AddedHolders
Q2 2024537,762$73.3M0.1%+80,258+17.5%AddedHolders
Q1 2024457,504$69.2M0.1%+285,933+166.7%AddedHolders
Q4 2023171,571$21.6M<0.1%+171,323+69,081.9%AddedHolders
Q3 2023248$23.2K<0.1%−13,724−98.2%ReducedHolders
Q2 202313,972$1.25M<0.1%−107,030−88.5%ReducedHolders
Q1 2023121,002$13.0M<0.1%−135,284−52.8%ReducedHolders
Q4 2022256,286$31.3M<0.1%+202,346+375.1%AddedHolders
Q3 202253,940$5.57M<0.1%−3,248−5.7%ReducedHolders
Q2 202257,188$5.32M<0.1%+57,188NewHolders
Q1 20220$00.0%−52,026−100.0%Sold outHolders
Q4 202152,026$7.00M<0.1%+42,848+466.9%AddedHolders
Q3 20219,178$1.46M<0.1%−280,497−96.8%ReducedHolders
Q2 2021289,675$38.1M<0.1%+174,760+152.1%AddedHolders
Q1 2021114,915$14.8M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.